
Natus Medical Incorporated NTUS
Quarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Interest Expense 2011-2026 | NTUS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.87 M | 3.66 M | 4.94 M | 6.79 M | 5.08 M | 430 K | 352 K | 438 K | 1.68 M | 489 K | 268 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.79 M | 268 K | 2.36 M |
Quarterly Interest Expense Natus Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 267 K | - | 332 K | 556 K | 766 K | - | 1.11 M | 976 K | 717 K | - | 1.17 M | 1.47 M | 1.53 M | - | 1.65 M | 1.64 M | 1.96 M | - | 1.04 M | 1.28 M | 980 K | - | 223 K | 97 K | 31 K | - | - | - | 1 K | - | 104 K | 184 K | 264 K | - | 138 K | 469 K | 477 K | - | 215 K | 8 K | 8 K | - | 47 K | 64 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.96 M | 1 K | 638 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.72 | 0.95 % | $ 153 M | ||
|
AxoGen
AXGN
|
167 K | $ 33.03 | -4.08 % | $ 1.52 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.07 | -1.09 % | $ 862 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.25 | 1.79 % | $ 1.66 B | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 36.66 | -0.27 % | $ 5.46 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 62.57 | -0.4 % | $ 92.6 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.41 | 0.48 % | $ 266 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.54 | -0.72 % | $ 1.07 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.76 | 1.35 % | $ 350 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.5 | 3.24 % | $ 131 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 81.26 | 0.26 % | $ 47.5 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.6 | 0.04 % | $ 122 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
7.68 M | $ 170.52 | -0.05 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.87 | 0.27 % | $ 1.14 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.42 | 3.38 % | $ 171 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.6 | 0.38 % | $ 1.23 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 85.01 | -2.12 % | $ 2.95 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.95 | -0.68 % | $ 374 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.97 | -1.49 % | $ 71.4 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.38 | 3.38 % | $ 56.1 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.52 | -0.13 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.89 | -0.89 % | $ 575 M | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | 3.22 % | $ 28.9 M |